Pharming Group N.V. (PHAR)
NASDAQ: PHAR · Real-Time Price · USD
15.44
-0.39 (-2.46%)
At close: Mar 6, 2026, 4:00 PM EST
15.26
-0.18 (-1.15%)
After-hours: Mar 6, 2026, 4:10 PM EST
Pharming Group Employees
Pharming Group had 404 employees as of December 31, 2024. The number of employees increased by 22 or 5.76% compared to the previous year.
Employees
404
Change (1Y)
22
Growth (1Y)
5.76%
Revenue / Employee
$896,718
Profits / Employee
$946
Market Cap
1.06B
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| AbCellera Biologics | 596 |
| Xeris Biopharma Holdings | 394 |
| UroGen Pharma | 287 |
| Geron | 229 |
| Inhibrx Biosciences | 161 |
| Precigen | 143 |
| DBV Technologies | 117 |
| Inventiva | 84 |
PHAR News
- 3 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR - GlobeNewsWire
- 8 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR - PRNewsWire
- 9 days ago - Pharming Group to report fourth quarter and full year 2025 financial results and provide business update on March 12 - GlobeNewsWire
- 15 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR - PRNewsWire
- 17 days ago - INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Pharming Group N.V. - PHAR - GlobeNewsWire
- 18 days ago - Pharming Group to present at the Oppenheimer 36th Annual Healthcare Life Sciences Conference - GlobeNewsWire
- 4 weeks ago - FDA Strikes Off European Biotech Pharming's Immune Deficiency Drug For Expanded Use In Pediatric Patients - Benzinga
- 4 weeks ago - FDA Refuses To Approve Expanded Use Of Pharming's Joenja In Children With APDS - Nasdaq